CONACYT Cathedratic at Health Science Center, Autonomous University of Aguascalientes, Mexico.
Maternal-Fetal Medicine and Therapy Research Center, Evidence-Based Health Care Department, in Behalf of the Iberoamerican Research Network in Translational, Molecular and Maternal-Fetal Medicine, Mexico City, Mexico.
J Diabetes Res. 2019 Aug 18;2019:7098470. doi: 10.1155/2019/7098470. eCollection 2019.
Free fatty acids, also known as nonesterified fatty acids, are proinflammatory molecules that induce insulin resistance in nonpregnant individuals. Nevertheless, the concentration of these molecules has not been systematically addressed in pregnant women.
This meta-analysis is aimed at evaluating the difference in free fatty acid plasma levels between women with gestational diabetes and healthy pregnant controls and their intrinsic and extrinsic determinants.
We performed a systematic search to find relevant studies published in English and Spanish using PubMed, SCOPUS, and ISI Web of Knowledge. We included observational studies measuring the mean plasma levels of free fatty acids among gestational diabetes and healthy pregnant women, with at least ten subjects being analyzed in each group. The standardized mean difference (SMD) by random effects modeling was used. Heterogeneity was assessed using Cochran's , , and statistics.
Among the 290 identified studies, twelve were selected for analysis. A total of 2426 women were included, from which 21% were diagnosed as having gestational diabetes. There were significantly higher levels of free fatty acids among women with gestational diabetes (SMD: 0.86; 0.54-1.18; < 0.001) when compared to healthy pregnant controls and between-study heterogeneity ( = 91%). The metaregression analysis showed that the gestational age at inclusion was the only cofactor influencing the mean levels of free fatty acids, indicating a trend towards lower plasma levels of free fatty acids later in gestation (estimate: -0.074; -0.143 to -0.004; = 0.036). No significant publication bias was found nor a trend towards greater results in small studies.
Women with gestational diabetes have higher levels of free fatty acids when compared to healthy pregnant controls. More investigation is needed to assess the potential role of free fatty acids in the prediction of gestational diabetes earlier in pregnancy.
游离脂肪酸,也称为非酯化脂肪酸,是一种促炎分子,可导致非妊娠个体胰岛素抵抗。然而,在孕妇中尚未系统地研究这些分子的浓度。
本荟萃分析旨在评估妊娠期糖尿病妇女与健康孕妇对照之间游离脂肪酸血浆水平的差异及其内在和外在决定因素。
我们使用 PubMed、SCOPUS 和 ISI Web of Knowledge 进行了系统搜索,以查找发表在英语和西班牙语中的相关研究。我们纳入了测量妊娠期糖尿病和健康孕妇游离脂肪酸平均血浆水平的观察性研究,每组至少分析了 10 例受试者。使用随机效应模型计算标准化均数差(SMD)。使用 Cochran's 、 和 统计量评估异质性。
在 290 项已确定的研究中,有 12 项被选入分析。共纳入 2426 名女性,其中 21%被诊断为妊娠期糖尿病。与健康孕妇对照组相比,妊娠期糖尿病妇女的游离脂肪酸水平显著升高(SMD:0.86;0.54-1.18; < 0.001),且组间存在异质性( = 91%)。荟萃回归分析显示,纳入时的孕龄是唯一影响游离脂肪酸平均水平的协变量,表明随着妊娠的进行,游离脂肪酸的血浆水平呈下降趋势(估计值:-0.074;-0.143 至-0.004; = 0.036)。未发现显著的发表偏倚,也未发现小型研究结果更倾向于阳性的趋势。
与健康孕妇对照组相比,妊娠期糖尿病妇女的游离脂肪酸水平更高。需要进一步研究来评估游离脂肪酸在更早预测妊娠期糖尿病中的潜在作用。